Efforts to Increase Representation in Prostate Cancer Clinical Trials at Lyndon B. Johnson Hospital

ConditionProstate Cancer

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexMale

Age18+

SponsorM.D. Anderson Cancer Center

About this trial

The main rationale underlying this study is that prostate cancer clinical trials are lacking representation from racial and ethnic minority groups. Study proposal aims to target barriers at the participant, investigator, and health system level through specific interventions to increase the percentage of participants from these backgrounds on cancer clinical trials.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

Video
Other intervention
Participants will watch a short video in clinic. Participants will complete the two validated scales before and after viewing the video.

Treatment groups

60 Participants

are divided into 2 treatment groups

Group A: Video Intervention to Prostate Cancer PatientExperimental treatment 1 intervention

Group B: To Conduct Educational Sessions with Frontline Oncology ProvidersExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

Safety and Adverse Events (AEs)

Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0

Time frame

Through study completion; an average of 1 year

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

M.D. Anderson Cancer Center

Lead sponsor

Source ClinicalTrials.gov

Apply now